Posted on: December 3, 2021
Infinity BiologiX (“IBX”), a leader in analytics, bioprocessing and biobanking, announced that the RT-PCR assay performed to detected SARS-CoV-2 in samples from individuals suspected of COVID-19 can detect the Omicron variant.
Posted on: September 21, 2021
Infinity BiologiX, Cytox, and Vanguard Pharma announce the US launch of the first, physician use only, polygenic test to predict the risk of cognitive decline due to Alzheimer’s disease.
Posted on: September 15, 2021
Leader in Biomaterial expertise, Infinity BiologiX, increases global footprint and capabilities with expansion into Europe with key acquisition. IBX, a... View Article
Posted on: June 23, 2021
Infinity BiologiX and Cytox collaborate to provide new genetic test to predict the risk of cognitive decline due to Alzheimer’s... View Article
Posted on: June 18, 2021
Infinity BiologiX announces new senior team members including Robin Grimwood as CEO Infinity BiologiX, LLC (IBX), a leading next-generation central... View Article
Posted on: May 25, 2021
Infinity BiologiX (IBX) Donates $50,000 to Sewa International and UNICEF USA to Support COVID-19 Response in India IBX joining with... View Article
Posted on: April 13, 2021
Infinity BiologiX (IBX) Awarded CDC Contract to Sequence Variants of COVID-19 Virus and Assist in Global Public Health Response IBX’s... View Article
Posted on: March 31, 2021
Infinity BiologiX (IBX) Announces Collaboration With Ginkgo Bioworks to Scale COVID Response Through Pooled Testing in K-12 Schools IBX is... View Article
Posted on: February 14, 2021
Infinity BiologiX Names Dr. Shareef Nahas as Vice President of Global Laboratory Operations and Clinical Services Dr. Sameer Kalghatgi also... View Article
Posted on: September 15, 2020
Telehealth Company, justmiine, Launches One-of-a-kind Platform, miinehealth, To Help Schools And Companies Reopen Safely During COVID-19 Unique, end-to-end platform allows... View Article
